Groundbreaking new study from UC San Francisco, researchers have found that children affected with SPD have quantifiable differences in brain structure

Pratik Mukherjee, MD, PhD

In a groundbreaking new study from UC San Francisco, researchers have found that children affected with SPD have quantifiable differences in brain structure, for the first time showing a biological basis for the disease that sets it apart from other neurodevelopmental disorders.

One of the reasons SPD has been overlooked until now is that it often occurs in children who also have ADHD or autism, and the disorders have not been listed in the Diagnostic and Statistical Manual used by psychiatrists and psychologists.

“Until now, SPD hasn’t had a known biological underpinning,” said senior author Pratik Mukherjee, MD, PhD, a professor of radiology and biomedical imaging and bioengineering at UCSF. “Our findings point the way to establishing a biological basis for the disease that can be easily measured and used as a diagnostic tool,” Mukherjee said.

The work is published in the open access online journal NeuroImage:Clinical.

Welcome to NeuroField

The NeuroField technology incorporates very low intensity, pulsed electromagnetic field (pEMF) stimulation, heart rate variability (HRV) and electroencephalography (EEG) all in one biofeedback system. The NeuroField X3000 is a four channel frequency generator that can generate pEMF frequencies from 0.31-300,000 Hz. The pEMF output ranges from 1-40 microtesla.. NeuroField low intensity pEMF is 10,000,000 times weaker than traditional rTMS (transcranial magnetic stimulation) which was approved by the FDA in 2008 for the treatment of depression. The NeuroField Q20 is a DC coupled, 19 channel EEG amplifier. The Q20 is sharp, clean EEG that has can used with the X3000 device to measure EEG in between pEMF stimulation utilizing the real time z-score procedure in the NeuroField software platform. The Q20 has also been integrated in the Neuroguide 19 channel LORETA and Surface neurofeedback z-score platform. In this way the Q20 is truely a versatile EEG amplifier that combines pEMF and z-score neurofeedback technologies. NeuroField was founded and invented by Nicholas Dogris, Ph.D. and Brad Wiitala, EE. NeuroField has evolved into the first pEMF device that measures physiological responses through EEG and HRV. Furthermore, NeuroField pEMF uses norm referenced, z-score, data to guide the brain to a regulated, normative state. As a result of these innovations, NeuroField brings the science of low intensity pEMF into the clinical setting.